Juan C Camacho1, Courtney Moreno1, Peter Harri1, and Pardeep Mittal1
1Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, United States
Synopsis
Cholangiocarcinoma
may demonstrate typical imaging manifestations and common patterns of organ
involvement, guiding diagnosis, and facilitating imaging follow up after
therapy. Adequate knowledge of tumoral
biology in cholangiocarcinoma and current image-guided therapeutic approaches,
along with imaging appearance of cholangiocarcinoma before and after
image-guided interventions is crucial for adequate diagnosis and surveillance .MR
imaging plays a key role for patient management, assessing therapy response and
patient surveillance.
Learning Goals:
1.Review basic
principles of cholangiocarcinoma and common dissemination pathways, including
differential diagnosis.
2.Discuss tumoral biology in cholangiocarcinoma and current image-guided therapeutic
approaches
3.Discuss a practical approach to determine key diagnostic imaging findings
and post-treatment changes following image-guided interventions for cholangiocarcinoma
on MR imaging.
.
Background Information and Content:
Basic presentation of colangiocarcinoma and differential
diagnosis for their mimics in a pattern-based approach.
MR evaluation: Review of MR imaging findings and algorithms
for an adequate imaging approach to cholangiocarcinoma.
Role of imaging in diagnosis and treatment of cholangiocarcinoma,
applying key concepts though a case presentation format.
Important concepts are
illustrated with schematic diagrams. Emphasis is placed on practical approaches,
image pattern recognition and image guided therapies evaluation.
Conclusions:
Cholangiocarcinoma
may demonstrate typical imaging manifestations and common patterns of organ
involvement, guiding diagnosis, and facilitating imaging follow up after
therapy.
MR imaging
plays a key role for patient management, assessing therapy response and patient
surveillance.
Adequate
knowledge of imaging appearance of cholangiocarcinoma before and after
image-guided interventions is crucial for adequate diagnosis and surveillance.
Acknowledgements
No acknowledgement found.References
-Ibrahim
SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu
RK, Masterson EJ, Newman SB, Benson A, Omary RA, Salem
R. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres:
results from a pilot study. Cancer. 2008;113:2119-28.
-Saxena
A, Bester L, Chua TC, Chu FC, Morris DL. Yttrium-90
radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary
assessment of this novel treatment option. Ann Surg Oncol. 2010;17:484-91.
-Camacho
J, Kokabi N, Xing M, Schuster D, Kim H. PERCIST
criteria predict survival at 3-months following intra-arterial resin-based
Yttrium-90 radioembolization therapy for unresectable Intrahepatic
Cholangiocarcinoma. Presented at CIRSE 2013.
-Camacho
J, Kokabi N, Xing M,Prajapati H, El Reyes B, D, Kim H. mRECIST Criteria Responses at an
early time point by contrast enhanced imaging Predicts Survival in Patients
with unresectable Intrahepatic Cholangiocarcinoma (ICC) refractory to standard
chemotherapy following Intra-arterial Yttrium-90 (Y-90) Resin-based
Radioembolization Presented at WCIO 2013.